Streetbeat News

Analyst Ratings

AAIC

JonesTrading analyst Jason Stewart reiterates a Buy rating on Arlington Asset Inv (NYSE:AAIC) and maintains a $5.5 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:13 pm

MRVL

Marvell Technology's stock is trading higher after Goldman Sachs maintained a Buy rating and raised its price target from $46 to $60.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:13 pm

BSX

Over the past 3 months, 14 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock, with an average price target of $57.29, implying an upside from the current price of $51.06. The current average has increased by 7.75% from the previous average price target of $53.17.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 12:09 pm

VRTX

Cantor Fitzgerald analyst Olivia Brayer reiterated an Overweight rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and maintained a $365 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:08 pm

HIMS

Analysts have provided ratings for Hims & Hers Health (NYSE:HIMS) within the last quarter, with an average price target of $12.83, up 4.31% from the previous average of $12.30. The current price of Hims & Hers Health is $9.07.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 12:08 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a $135 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:06 pm

IAC

Over the past 3 months, 10 analysts have published their opinion on IAC (NASDAQ:IAC) stock, with an average 12-month price target of $79.8, up 7.84% from the previous average of $74. The ratings include 4 bullish, 5 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 12:05 pm

IOVA

In the last quarter, 8 analysts rated Iovance Biotherapeutics (NASDAQ:IOVA) with an average price target of $24.25, a 21.25% increase from the previous average of $20. The current price of IOVA is $7.55, implying an upside potential.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 12:04 pm

PDD

Benchmark analyst Fawne Jiang maintains a Buy rating on PDD Holdings (NASDAQ:PDD) and raises the price target from $106 to $25.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:01 pm

ONTO

Stifel analyst Brian Chin maintains a Buy rating on Onto Innovation (NYSE:ONTO) and raises the price target from $97 to $124.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:00 pm